1. Home
  2. JLS vs PMN Comparison

JLS vs PMN Comparison

Compare JLS & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Mortgage and Income Fund

JLS

Nuveen Mortgage and Income Fund

HOLD

Current Price

$17.39

Market Cap

100.6M

Sector

Finance

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$10.35

Market Cap

115.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JLS
PMN
Founded
2009
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.6M
115.5M
IPO Year
2009
2022

Fundamental Metrics

Financial Performance
Metric
JLS
PMN
Price
$17.39
$10.35
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
27.4K
16.1K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
9.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.29
$0.29
52 Week High
$19.09
$27.40

Technical Indicators

Market Signals
Indicator
JLS
PMN
Relative Strength Index (RSI) 30.67 51.45
Support Level N/A $10.55
Resistance Level $18.76 $11.37
Average True Range (ATR) 0.26 0.58
MACD -0.02 0.09
Stochastic Oscillator 4.23 74.37

Price Performance

Historical Comparison
JLS
PMN

About JLS Nuveen Mortgage and Income Fund

Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. The Fund's investment objective is to provide a high level of current income.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: